Influence of Darolutamide on Cabazitaxel Systemic Exposure

Clin Pharmacokinet. 2022 Oct;61(10):1471-1473. doi: 10.1007/s40262-022-01159-6. Epub 2022 Jul 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgen Receptor Antagonists
  • Humans
  • Male
  • Prostatic Neoplasms, Castration-Resistant*
  • Pyrazoles
  • Taxoids* / adverse effects

Substances

  • Androgen Receptor Antagonists
  • Pyrazoles
  • Taxoids
  • darolutamide
  • cabazitaxel

Associated data

  • NTR/NL8611